Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 3Thoracic 2NET 1Head & Neck 1Endocrine 1CNS 1Breast 1

Conditions

Neuroendocrine Tumors 7Pheochromocytoma 4Paraganglioma 4Adrenocortical Carcinoma 4Thyroid Neoplasms 3Thyroid Cancer, Papillary 3Adenocarcinoma, Follicular 3Neoplasm Metastasis 2Adenoma, Islet Cell 2Vulvar Neoplasms 1Uveal Melanoma 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Small Cell Lung Carcinoma 1Seminoma 1Rare Diseases 1Pseudomyxoma Peritonei 1Prostatic Neoplasms 1Perivascular Epithelioid Cell Neoplasms 1Parathyroid Neoplasms 1Paranasal Sinus Neoplasms 1Pancreatic Neoplasms 1Paget Disease, Extramammary 1Non functioning pancreatic endocrine tumor 1Neurofibrosarcoma 1Nasopharyngeal Carcinoma 1Multiple Sclerosis 1Mouth Neoplasms 1Metastatic Digestive System Neuroendocrine Tumor G1 1Melanoma 1

Interventions

pentetreotide 1fludarabine phosphate 1entinostat 1Specimen Handling 1Rose Bengal 1Melphalan 1Magnetic Resonance Spectroscopy 1LY2940680 1Interleukin-13 1Fluorodeoxyglucose F18 1Cyclophosphamide 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uveal Melanoma × Specimen Handling × Endocrine × Clear all
NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Stanford University

Phase 1 Recruiting
18 enrolled
BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡